Catalyst Pharmaceuticals, Inc.
CPRX
$31.16
$0.020.06%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 20.94% | -0.16% | 1.30% | -8.16% | 1.43% |
| Total Depreciation and Amortization | 2.47% | 1.29% | -0.47% | 0.00% | 0.02% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 59.39% | -122.07% | 12.27% | 879.26% | -13.42% |
| Change in Net Operating Assets | 14.05% | 61.72% | -4,288.48% | 113.42% | -258.56% |
| Cash from Operations | 32.74% | 38.39% | -54.50% | 18.74% | -15.29% |
| Capital Expenditure | 15.63% | -- | 100.00% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 15.63% | -- | 100.00% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 76.01% | -67.63% | 162.26% | -53.83% | -20.00% |
| Repurchase of Common Stock | 43.25% | -- | 100.00% | 65.89% | -38.36% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.42% | -8.93% | -2.06% | -3.13% | 0.18% |
| Cash from Financing | 49.68% | -649.63% | 433.72% | -71.50% | -30.97% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 142.17% | -48.02% | -48.59% | 14.33% | -16.11% |